Mexico - Delayed Quote MXN
Ocugen, Inc. (OCGN.MX)
15.20
+0.30
+(2.01%)
At close: May 5 at 11:43:50 AM CST
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-42,142
-42,142
-62,054
-60,079
-47,941
Investing Cash Flow
-3,385
-3,385
3,077
-16,967
-1,816
Financing Cash Flow
64,858
64,858
20,881
59,475
120,676
End Cash Position
58,821
58,821
39,462
77,563
95,109
Capital Expenditure
-3,385
-3,385
-10,476
-4,457
-939
Issuance of Capital Stock
--
--
20,804
59,567
129,211
Issuance of Debt
30,000
30,000
500
500
--
Repayment of Debt
--
--
--
--
-10
Free Cash Flow
-45,527
-45,527
-72,530
-64,536
-48,880
12/31/2021 - 6/8/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ATOS.MX Atossa Therapeutics, Inc.
17.20
+4.24%
MRNA.MX Moderna, Inc.
550.00
+1.66%
ADVM Adverum Biotechnologies, Inc.
3.5900
+2.87%
FDMT 4D Molecular Therapeutics, Inc.
3.5700
-5.05%
OCUL Ocular Therapeutix, Inc.
7.73
-12.16%
INO Inovio Pharmaceuticals, Inc.
1.8600
-3.12%
ATOS Atossa Therapeutics, Inc.
0.8798
+2.85%